Project Grant HT94252510289
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Lebanon, NH 03756, USA
Similar Awards
This $1,354,428 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a family-centered e-health intervention to promote patient and caregiver well-being in adolescent and emerging adult pediatric brain tumor survivors. The grant was awarded to the Children's Hospital Medical Center in Cincinnati, Ohio, which will serve as the prime awardee. The project duration is from September 1, 2024 to August 31, 2028. The...
This Department of Defense (CFDA 12.420 - Military Medical Research and Development) Project Grant award of $2,499,990.00 was provided to the Dartmouth-Hitchcock Clinic, doing business as Dartmouth-Hitchcock Obligated Group, to conduct a multicenter randomized controlled trial evaluating the use of incisional negative pressure wound therapy to reduce infection and complications in high-risk fractures. The grant has an award date of September 1, 2023 and an ultimate completion date of August...
The Defense Health Agency awarded Trustees of Dartmouth College a $2,031,453 project grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop machine learning strategies for predicting suicide risk using clinical note text from May 1, 2023 to April 30, 2026. Dartmouth College will utilize subawards to Cedars-Sinai Medical Center, Vanderbilt University Medical Center, and Veterans Education And Research Association Of Northern New England, Inc. to...
The federal Project Grant award, valued at $1,177,731.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by the Dartmouth-Hitchcock Clinic, a non-profit healthcare provider and academic medical center, to increase epilepsy self-management access for veterans through a "partnered hub and spoke model" approach. The project aims to transform healthcare for military service members and...
The Defense Health Agency has awarded a $657,263 project grant under the Military Medical Research and Development program (CFDA 12.420) to the Dana-Farber Cancer Institute, Inc. (d.b.a. DFCI) in Boston, MA. The award, effective September 1, 2024 through August 31, 2027, will support DATA-DRIVEN BIOMARKER-INFORMED DECISION ANALYTICS IN MELANOMA: IMPROVING EFFICACY AND REDUCING TOXICITY OF IMMUNE CHECKPOINT BLOCKADE. Through this grant, DFCI will conduct research to develop data-driven...
This $1,175,982 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a telehealth intervention aimed at improving quality of life and pancreatic cancer survivorship. The grant, awarded to the Beckman Research Institute of the City of Hope, a nonprofit research organization, will fund the development and implementation of this telehealth program over a 3-year period from August 2024 to July 2027. The project will leverage...
This $725,000 Project Grant awarded by the Defense Health Agency supports research at Dartmouth-Hitchcock Clinic to develop photodynamic therapy (PDT) for preventing infection at the skin-implant interface of osseointegrated prostheses. The research is funded under CFDA Program 12.420 - Military Medical Research and Development, which focuses on advancing treatments and care for military service members and veterans. Dartmouth-Hitchcock is collaborating with Wake Forest University Health...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The Defense Health Agency awarded Massachusetts General Hospital a $368,238 project grant under the Military Medical Research and Development program (CFDA 12.420) from September 1, 2023 through August 31, 2026. The grant will fund research to determine if microbiome-derived cell fragments in the brain accelerate transition from traumatic brain injury to Alzheimer's disease or related dementias. As a leading academic medical center, Massachusetts General Hospital will leverage its expertise in...
The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...